false12-312022Q30001845580P10D00018455802022-01-012022-09-300001845580us-gaap:CommonClassAMember2022-11-140001845580us-gaap:CommonClassBMember2022-11-1400018455802022-09-3000018455802021-12-310001845580us-gaap:CommonClassBMember2021-12-310001845580us-gaap:CommonClassBMember2022-09-300001845580us-gaap:CommonClassAMember2022-09-300001845580us-gaap:CommonClassAMember2021-12-3100018455802021-07-012021-09-3000018455802021-01-272021-09-3000018455802022-07-012022-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-07-012022-09-300001845580us-gaap:CommonClassBMember2021-07-012021-09-300001845580us-gaap:CommonClassBMember2021-01-272021-09-300001845580us-gaap:CommonClassAMember2022-07-012022-09-300001845580us-gaap:CommonClassBMember2022-07-012022-09-300001845580us-gaap:CommonClassAMember2021-01-272021-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-01-272021-09-300001845580us-gaap:CommonClassAMember2022-01-012022-09-300001845580us-gaap:CommonClassBMember2022-01-012022-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-01-012022-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-07-012021-09-300001845580us-gaap:CommonClassAMember2021-07-012021-09-300001845580us-gaap:AdditionalPaidInCapitalMember2021-01-2600018455802021-01-260001845580us-gaap:RetainedEarningsMember2021-12-310001845580us-gaap:RetainedEarningsMember2021-01-260001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001845580us-gaap:AdditionalPaidInCapitalMember2021-12-310001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-260001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-260001845580us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310001845580us-gaap:AdditionalPaidInCapitalMember2021-01-272021-03-3100018455802021-01-272021-03-3100018455802022-01-012022-03-310001845580us-gaap:RetainedEarningsMember2021-01-272021-03-310001845580us-gaap:RetainedEarningsMember2022-01-012022-03-310001845580us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-01-012022-03-310001845580us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-01-272021-03-310001845580us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-04-012021-06-300001845580us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-3000018455802021-04-012021-06-300001845580us-gaap:RetainedEarningsMember2021-04-012021-06-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-03-310001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-04-012021-06-300001845580us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001845580us-gaap:RetainedEarningsMember2022-07-012022-09-3000018455802022-04-012022-06-300001845580us-gaap:RetainedEarningsMember2022-04-012022-06-300001845580us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001845580us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-04-012022-06-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-07-012022-09-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-01-272021-03-310001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-07-012022-09-300001845580us-gaap:RetainedEarningsMember2021-07-012021-09-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-07-012021-09-300001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-07-012021-09-300001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-04-012022-06-300001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-06-3000018455802022-06-300001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-09-300001845580us-gaap:RetainedEarningsMember2021-09-300001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2022-09-300001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-03-310001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-03-3100018455802021-06-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-03-310001845580us-gaap:AdditionalPaidInCapitalMember2022-06-300001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-09-300001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-06-300001845580us-gaap:AdditionalPaidInCapitalMember2021-06-300001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-03-3100018455802022-03-310001845580us-gaap:AdditionalPaidInCapitalMember2022-09-300001845580us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-06-300001845580us-gaap:AdditionalPaidInCapitalMember2022-03-310001845580us-gaap:RetainedEarningsMember2021-06-300001845580us-gaap:RetainedEarningsMember2021-03-310001845580us-gaap:RetainedEarningsMember2022-09-300001845580us-gaap:RetainedEarningsMember2022-03-310001845580us-gaap:RetainedEarningsMember2022-06-3000018455802021-09-300001845580us-gaap:AdditionalPaidInCapitalMember2021-03-3100018455802021-03-310001845580us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-09-300001845580us-gaap:CommonClassAMemberus-gaap:CommonStockMember2022-06-300001845580us-gaap:AdditionalPaidInCapitalMember2021-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-12-310001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-01-260001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-01-012022-03-310001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-04-012021-06-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-04-012022-06-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-01-272021-03-310001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-06-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-03-310001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2022-03-310001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-09-300001845580tcva:CommonClassAMandatorilyRedeemableStockMember2021-06-300001845580us-gaap:CommonClassAMember2022-03-310001845580us-gaap:CommonClassAMember2021-06-300001845580us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2021-04-162021-04-160001845580us-gaap:CommonClassAMemberus-gaap:IPOMember2021-04-162021-04-160001845580us-gaap:OverAllotmentOptionMember2021-04-162021-04-160001845580us-gaap:OverAllotmentOptionMember2021-04-160001845580us-gaap:CommonClassAMemberus-gaap:IPOMember2021-04-160001845580us-gaap:CommonClassAMemberus-gaap:PrivatePlacementMember2021-04-160001845580us-gaap:IPOMember2021-04-162021-04-160001845580us-gaap:IPOMember2021-04-160001845580us-gaap:PrivatePlacementMember2021-04-162021-04-1600018455802021-04-162021-04-160001845580srt:MinimumMember2022-01-012022-09-300001845580srt:MaximumMember2022-01-012022-09-300001845580srt:MaximumMember2021-04-160001845580tcva:SponsorCommitmentLoanMemberus-gaap:InvestorMember2022-09-300001845580us-gaap:InvestorMembertcva:SponsorCommitmentLoanMember2022-01-012022-09-3000018455802021-04-160001845580us-gaap:CommonClassBMember2021-09-3000018455802021-01-012021-12-310001845580us-gaap:CommonClassAMemberus-gaap:OverAllotmentOptionMember2021-04-162021-04-160001845580us-gaap:OverAllotmentOptionMemberus-gaap:CommonClassAMember2021-04-160001845580us-gaap:InvestorMemberus-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2022-01-012022-09-300001845580us-gaap:InvestorMemberus-gaap:CommonClassBMember2021-01-292021-01-290001845580srt:MaximumMemberus-gaap:CommonClassBMember2021-01-290001845580us-gaap:CommonClassBMember2021-01-290001845580us-gaap:CommonClassBMember2021-04-160001845580us-gaap:InvestorMemberus-gaap:CommonClassBMember2022-01-012022-09-300001845580srt:MinimumMemberus-gaap:CommonClassAMember2022-09-300001845580srt:MinimumMemberus-gaap:CommonClassAMember2022-01-012022-09-300001845580tcva:WorkingCapitalLoansMembertcva:SponsorCompanySFoundingTeamMembersOrAnyOfTheirAffiliatesMember2022-01-012022-09-300001845580tcva:SponsorCompanySFoundingTeamMembersOrAnyOfTheirAffiliatesMembertcva:WorkingCapitalLoansMember2022-09-300001845580tcva:SponsorCompanySFoundingTeamMembersOrAnyOfTheirAffiliatesMembertcva:WorkingCapitalLoansMember2021-12-310001845580srt:AffiliatedEntityMember2022-09-300001845580srt:AffiliatedEntityMember2021-12-310001845580srt:MaximumMember2022-09-300001845580us-gaap:FairValueMeasurementsRecurringMember2021-12-310001845580us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001845580us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001845580us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001845580us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001845580us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001845580us-gaap:FairValueMeasurementsRecurringMember2022-09-300001845580us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001845580us-gaap:CommonClassBMembersrt:DirectorMember2022-06-082022-06-080001845580us-gaap:CommonClassBMembersrt:DirectorMember2022-01-012022-09-300001845580us-gaap:CommonClassBMembersrt:DirectorMember2022-09-300001845580us-gaap:RestrictedStockMember2021-12-310001845580us-gaap:RestrictedStockMember2022-01-012022-09-300001845580us-gaap:RestrictedStockMember2022-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharestcva:Businessxbrli:puretcva:Individualtcva:Vote

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-40327

TCV ACQUISITION CORP.

(Exact Name of Registrant as Specified in Its Charter)

Cayman Islands		98-1580306
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

250 Middlefield Road Menlo Park, CA		94025
(Address of principal executive offices)		(Zip Code)

(650) 614-8200

(Issuer’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A ordinary shares		TCVA		The NASDAQ Capital Market LLC

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer	☒	Smaller reporting company	☒

		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of November 14, 2022, there were 41,100,000 Class A ordinary shares, $0.0001 par value and 10,000,000 Class B ordinary shares, $0.0001 par value, issued and outstanding.

TCV ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED AND NINE MONTHS ENDED SEPTEMBER 30, 2022

TABLE OF CONTENTS

			Page
Part I. Financial Information
	Item 1. Condensed Financial Statements (Unaudited)
		Condensed Balance Sheets as of September 30, 2022 and December 31, 2021	2
		Condensed Statements of Operations for the Three Months Ended September 30, 2022 and September 30, 2021 and for the Nine Months Ended September 30, 2022 and For the Period from January 27, 2021 (inception) through September 30, 2021	3
		Condensed Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) for the Nine Months Ended September 30, 2022 and For the Period from January 27, 2021 (inception) through September 30, 2021	4
		Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2022 and For the Period from January 27, 2021 through September 30, 2021	5
		Notes to Condensed Financial Statements	6
	Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		16
	Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk		18
	Item 4. Controls and Procedures		18
Part II. Other Information			19
	Item 1. Legal Proceedings		19
	Item 1A. Risk Factors		19
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		19
	Item 3. Defaults Upon Senior Securities		20
	Item 4. Mine Safety Disclosures		20
	Item 5. Other Information		20
	Item 6. Exhibits		20
Part III. Signatures			22

F-1

Table of Contents

TCV ACQUISITION CORP.

CONDENSED BALANCE SHEETS

	September 30, 2022			December 31, 2021
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	178,535		$	621,420
Prepaid expenses		313,642			563,037
Marketable securities held in Trust Account		402,408,485			-
Total current assets		402,900,662			1,184,457
Marketable securities held in Trust Account		-			400,022,668
Non-current prepaid expenses		-			143,897
Total Assets	$	402,900,662		$	401,351,022

Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity (Deficit)
Current liabilities:
Accounts payable	$	-		$	300
Due to affiliates		39,757			-
Accrued professional fees		220,688			68,838
Accrued offering costs		-			70,000
Deferred underwriting commissions		14,000,000			-
Total current liabilities		14,260,445			139,138
Deferred underwriting commissions		-			14,000,000
Total liabilities		14,260,445			14,139,138

Commitments and Contingencies (Note 6)

Class A ordinary shares subject to possible redemption, $0.0001 par value; 40,000,000 shares subject to possible redemption at $10.00 per share at accreted value		396,012,434			384,977,314

Shareholders’ Equity (Deficit):
Preference shares, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding		-			-
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,100,000 shares issued and outstanding (excluding 40,000,000 shares subject to possible redemption)		110			110
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 10,000,000 shares issued and outstanding		1,000			1,000
Additional paid-in capital		-			2,939,363
Accumulated deficit		(7,373,327	)		(705,903	)
Total shareholders’ equity (deficit)		(7,372,217	)		2,234,570
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Equity (Deficit)	$	402,900,662		$	401,351,022

The accompanying notes are an integral part of these unaudited financial statements.

F-2

Table of Contents

TCV ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)

	For the three months ended			For the three months ended			For the nine months ended			For the period from January 27, 2021
	September 30, 2022			September 30, 2021			September 30, 2022			(inception) through September 30, 2021

General and administrative expenses	$	316,152		$	261,086		$	958,314		$	510,999
Loss from operations		(316,152	)		(261,086	)		(958,314	)		(510,999	)
Other income:
Dividend and interest income		1,806,082			5,168			2,386,647			14,263
Net income (loss)	$	1,489,930		$	(255,918	)	$	1,428,333		$	(496,736	)

Basic and diluted weighted average shares outstanding of Class A ordinary shares subject to possible redemption		40,000,000			40,000,000			40,000,000			27,206,478

Basic and dilued net income (loss) per share, Class A ordinary shares subject to possible redemption (See Note 2)	$	0.10		$	(0.01	)	$	0.13		$	(0.01	)

Basic and diluted weighted average shares outstanding of Class A ordinary shares		1,100,000			1,100,000			1,100,000			748,178

Basic and diluted net income (loss) per share, Class A ordinary shares (See Note 2)	$	0.03		$	(0.01	)	$	0.03		$	(0.01	)

Basic and diluted weighted average shares outstanding of Class B ordinary shares		10,000,000			10,000,000			10,000,000			9,600,202

Basic and diluted net income (loss) per share, Class B ordinary shares (See Note 2)	$	0.03		$	(0.01	)	$	0.03		$	(0.01	)

The accompanying notes are an integral part of these unaudited financial statements.

F-3

Table of Contents

TCV ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY (DEFICIT)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2022

(Unaudited)

	Ordinary Shares Subject to Possible Redemption				Ordinary Shares								Additional						Total
	Class A				Class A				Class B				Paid-in			Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Equity (Deficit)
Balance - December 31, 2021		40,000,000	$	384,977,314		1,100,000	$	110		10,000,000	$	1,000	$	2,939,363		$	(705,903	)	$	2,234,570
Issuance of Class B ordinary shares to Sponsor		-		-		-		-		-		-		-			-			-
Issuance of Class A ordinary shares, net of $23,107,213 issuance costs		-		-		-		-		-		-		-			-			-
Accretion of Class A ordinary shares to accreted value		-		2,870,441		-		-		-		-		(2,870,441	)		-			(2,870,441	)
Net income (loss)		-		-		-		-		-		-		-			(342,610	)		(342,610	)
Balance - March 31, 2022		40,000,000		387,847,755		1,100,000		110		10,000,000		1,000		68,922			(1,048,513	)		(978,481	)
Accretion of Class A ordinary shares to accreted value		-		3,422,981		-		-		-		-		(68,922	)		(3,354,059	)		(3,422,981	)
Net income (loss)		-		-		-		-		-		-		-			281,013			281,013
Balance - June 30, 2022		40,000,000		391,270,736		1,100,000		110		10,000,000		1,000		-			(4,121,559	)		(4,120,449	)
Accretion of Class A ordinary shares to accreted value		-		4,741,698		-		-		-		-		-			(4,741,698	)		(4,741,698	)
Net income (loss)		-		-		-		-		-		-		-			1,489,930			1,489,930
Balance - September 30, 2022		40,000,000	$	396,012,434		1,100,000	$	110		10,000,000	$	1,000	$	-		$	(7,373,327	)	$	(7,372,217	)

TCV ACQUISITION CORP.

CONDENSED STATEMENTS OF CHANGES IN ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY (DEFICIT)

FROM THE PERIOD JANUARY 27, 2021 (INCEPTION) THROUGH SEPTEMBER 30, 2021

(Unaudited)

	Ordinary Shares Subject to Possible Redemption				Ordinary Shares								Additional						Total
	Class A				Class A				Class B				Paid-in			Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Equity
Balance - January 27, 2021 (inception)		-	$	-		-	$	-		-	$	-	$	-		$	-		$	-
Issuance of Class B ordinary shares to Sponsor		-		-		-		-		10,000,000		1,000		24,000			-			25,000
Net income (loss)		-		-		-		-		-		-		-			(5,187	)		(5,187	)
Balance - March 31, 2021		-		-		-		-		10,000,000		1,000		24,000			(5,187	)		19,813
Issuance of Class A ordinary shares, net of $23,107,213 issuance costs		40,000,000		376,892,787		1,100,000		110		-		-		10,999,890			-			11,000,000
Accretion of Class A ordinary shares to accreted value		-		2,340,000		-		-		-		-		(2,340,000	)		-			(2,340,000	)
Net income (loss)		-		-		-		-		-		-		-			(235,631	)		(235,631	)
Balance - June 30, 2021		40,000,000		379,232,787		1,100,000		110		10,000,000		1,000		8,683,890			(240,818	)		8,444,182
Accretion of Class A ordinary shares to accreted value		-		2,864,436		-		-		-		-		(2,864,436	)		-			(2,864,436	)
Net income (loss)		-		-		-		-		-		-		-			(255,918	)		(255,918	)
Balance - September 30, 2021		40,000,000	$	382,097,223		1,100,000	$	110		10,000,000	$	1,000	$	5,819,454		$	(496,736	)	$	5,323,828

The accompanying notes are an integral part of these unaudited financial statements.

F-4

Table of Contents

TCV ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(unaudited)

	For the nine months ended			For the period from January 27, 2021
	September 30, 2022			(inception) through September 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$	1,428,333		$	(496,736	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Dividends and interest earned in Trust Account		(2,385,817	)		(14,217	)
Changes is operating assets and liabilities:
Prepaid expenses		393,292			(854,548	)
Accounts payable		(300	)		25,915
Due to affiliates		39,757			-
Accrued professional fees		151,850			69,635
Net cash used in operating activities		(372,885	)		(1,269,951	)

Cash Flows from Investing Activities:
Investments in marketable securities held in Trust Account		-			(400,000,000	)
Net cash used in investing activities		-			(400,000,000	)

Cash Flows from Financing Activities:
Payment of offering costs		(70,000	)		(9,006,313	)
Proceeds from note payable - related party		-			109,140
Payment of note payable - related party		-			(109,140	)
Proceeds from Initial Public Offering		-			400,000,000
Proceeds from Private Placement Shares		-			11,000,000
Proceeds from issuance of Class B shares		-			25,000
Net cash (used in) provided by financing activities		(70,000	)		402,018,687

Net change in cash		(442,885	)		748,736

Cash - beginning of the period		621,420			-
Cash - end of the period	$	178,535		$	748,736

Supplemental disclosure of noncash investing and financing activities:
Accretion of Class A ordinary shares to accreted value	$	11,035,120		$	5,204,436
Deferred offering costs included in accrued expenses	$	-		$	100,900
Deferred underwriting commissions	$	-		$	14,000,000

The accompanying notes are an integral part of these unaudited financial statements.

F-5

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND LIQUIDITY

TCV Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 27, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of completing a Business Combination. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

All activity for the period from January 27, 2021 (inception) through September 30, 2022 relates to the Company’s formation, its initial public offering (the “Initial Public Offering”) and looking for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest and dividend income from the proceeds derived from the Initial Public Offering.

On February 23, 2021, the former sponsor (“Former Sponsor”), TCV Acquisition Holdings, a Cayman Islands limited liability, transferred its interests in and obligations with respect to the Company to TCV Acquisition Holdings, L.P., an exempted limited partnership organized under the laws of the Cayman Islands (“Sponsor”).

The registration statement for the Company’s Initial Public Offering was declared effective on April 13, 2021. On April 16, 2021, the Company consummated its Initial Public Offering of 40,000,000 Class A ordinary shares (the “Public Shares”), including the 5,000,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $23.1 million, of which $14.0 million was for deferred underwriting commissions (see Note 6).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 1,100,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to TCV Acquisition Holdings 2, L.P., an exempted limited partnership organized under the laws of the Cayman Islands (“Sponsor 2”, collectively with Sponsor, the “Sponsors”), generating gross proceeds of $11.0 million (see Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, $400.0 million ($10.00 per Public Share) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account to the Company’s shareholders, as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding any deferred underwriters’ fees and taxes payable on the income earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.

The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval in connection with a Business Combination, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association (the “Amended and restated memorandum and articles of association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to this Initial Public Offering (the “Initial Shareholders”) agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders agreed to waive their redemption rights with respect to their Founder Shares and Private Placement Shares in connection with the completion of a Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In addition, the Company agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor.

F-6

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or April 16, 2023 (or 27 months from the closing of the Initial Public Offering, or July 16, 2023, if the Company has executed a letter of intent, agreement in principle or definitive agreement for the initial Business Combination within 24 months from the closing of the Initial Public Offering but has not completed the initial Business Combination within such 24 month period) (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.

The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable; provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

F-7

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

Liquidity and capital resources

On April 16, 2021, the Company consummated its Initial Public Offering and raised proceeds from a private placement (see Note 4) at which time capital in excess of the funds deposited in the trust and/or used to fund offering expenses was released to the Company for general working capital purposes. As of September 30, 2022, a total of $402.4 million was in the Trust Account, and we had $0.2 million of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. Based on our available cash and our anticipated expenses, we may not have sufficient cash to pay our obligations as they become due for at least the next twelve months. As such, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern. As a result and in order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, on October 26, 2022, our Sponsor made a noncancelable and irrevocable commitment to provide a loan to the Company of up to $1 million to be drawn over the course of 13 months from the date of the letter (see Note 5). The loan commitment from the sponsor sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or the end of the Combination Period. Over this time period, the Company will be using these funds for paying existing accounts payable, ongoing professional fees, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Risks and uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic on the industry, along with the rising conflict between Russia and Ukraine, and resulting market volatility and has concluded that while it is reasonably possible that these events could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.

The ongoing conflict in Ukraine—along with the responses of the governments of the United States, EU member states, the United Kingdom, and other nations—have the potential to materially adversely affect a potential target business’s operations or assets in—or (direct or indirect) dealings with parties organized or located within—Ukraine, Russia, and Belarus. Due to recent geopolitical developments, the United States, European Union, United Kingdom, and other nations have announced or threatened new sanctions and export restrictions targeting Russian and Belarusian individuals and entities, as well as disputed territories within Ukraine. Russia and its allies may respond with countermeasures, which could further restrict the target business’s operations in or related to the foregoing countries. It is unclear how long existing restrictions (and countermeasures) will remain in place or whether new restrictions (or countermeasures) may be imposed. Existing restrictions have negatively impacted the Russian economy, and there can be no guarantee that existing (or new) restrictions or countermeasures will not materially adversely affect the Russian (or global) economy. Any of the foregoing could have a material adverse impact on a potential target business’s financial condition, results of operations, or prospects.

The Company’s business could be also impacted by downturns in the financial markets or in economic conditions, inflation, increases in interest rates. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s business.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the periods presented.

F-8

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2021, as filed with the SEC on March 28, 2022. The interim results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods.

Emerging growth company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts and treasury notes in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage or Securities Investor Protection Coverage. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company held cash equivalents in short-term investments as of September 30, 2022 and December 31, 2021.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 825, “Financial Instruments”, approximates the carrying amounts represented in the balance sheets due to the short term nature of these amounts.

Marketable Securities Held in Trust Account

As of September 30, 2022 and December 31, 2021, the Company’s portfolio of investments held in the Trust Account are comprised solely of cash, U.S. Treasury bills, notes, and other obligations issued or guaranteed by the U.S. Treasury. These securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividends and interest income in the accompanying statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

F-9

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

	•	Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
	•	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	•	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares issued as part of the initial public offering contain certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are classified as temporary equity and are accreted from the initial carrying amount to the redemption value over the period from the date of issuance to the earliest redemption date of the instrument using the effective interest method. For the nine months ended September 30, 2022 and for the period from January 27, 2021 (inception) through September 30, 2021, the accretion for the Class A ordinary shares subject to possible redemption was approximately $11.0 million and $5.2 million, respectively. For the three months ended September 30, 2022 and September 30, 2021, the accretion for the Class A ordinary shares subject to possible redemption was approximately $4.7 million and $2.9 million, respectively.

The reconciliation of Class A ordinary shares subject to possible redemption as of September 30, 2022 is as follows:

Gross proceeds	$	400,000,000
Issuance costs		(23,107,213	)
Accretion		19,119,647
	$	396,012,434

The reconciliation of Class A ordinary shares subject to possible redemption as of December 31, 2021 is as follows:

Gross proceeds	$	400,000,000
Issuance costs		(23,107,213	)
Accretion		8,084,527
	$	384,977,314

Use of Estimates

The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in capital.

F-10

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

Offering Costs

Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to our initial public offering. Offering costs amounting to approximately $23.1 million were accounted for as a reduction to the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering.

Stock Based Compensation

Stock-based compensation expense associated with the Company’s equity awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures are recognized as incurred.

Net Income (Loss) per Ordinary Share

Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding during the period. Weighted average shares for January 27, 2021 (inception) through September 30, 2021, were reduced for the effect of an aggregate of 1,250,000 Class B ordinary shares that were subject to forfeiture until the overallotment option was exercised in full by the underwriters on April 16, 2021. The Company’s condensed statements of operations include a presentation of loss per ordinary share subject to redemption in a manner similar to the two-class method of loss per share. With respect to the accretion of the Class A Shares subject to possible redemption and consistent with ASC 480-10-S99-3A, the Company has elected to treat only the portion of the accretion that reflects a redemption in excess of fair value in the same manner as dividends in the calculation of net income (loss) per ordinary share.

As of September 30, 2022 and December 31, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.

A reconciliation of net income (loss) per ordinary share is as follows:

For the three months ended September 30, 2022	Class A ordinary shares subject to possible redemption		Class A ordinary shares		Class B ordinary shares
Allocation of undistributable income (losses)	$	1,166,286	$	32,073	$	291,571
Redemption amount in excess of fair value		2,741,698		-		-
Net income (loss) per ordinary share	$	3,907,984	$	32,073	$	291,571

Weighted average shares outstanding, basic and diluted		40,000,000		1,100,000		10,000,000

Basic and diluted net income (loss) per ordinary share	$	0.10	$	0.03	$	0.03

For the nine months ended September 30, 2022	Class A ordinary shares subject to possible redemption		Class A ordinary shares		Class B ordinary shares
Allocation of undistributable income (losses)	$	1,118,069	$	30,747	$	279,517
Redemption amount in excess of fair value		4,012,434		-		-
Net income (loss) per ordinary share	$	5,130,503	$	30,747	$	279,517

Weighted average shares outstanding, basic and diluted		40,000,000		1,100,000		10,000,000

Basic and diluted net income (loss) per ordinary share	$	0.13	$	0.03	$	0.03

F-11

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

For the three months ended September 30, 2021	Class A ordinary shares subject to possible redemption			Class A ordinary shares			Class B ordinary shares
Allocation of undistributable income (losses)	$	(200,327	)	$	(5,509	)	$	(50,082	)

Net income (loss) per ordinary share	$	(200,327	)	$	(5,509	)	$	(50,082	)

Weighted average shares outstanding, basic and diluted		40,000,000			1,100,000			10,000,000

Basic and diluted net income (loss) per ordinary share	$	(0.01	)	$	(0.01	)	$	(0.01	)

For the period from January 27, 2021 (inception) through September 30, 2021	Class A ordinary shares subject to possible redemption			Class A ordinary shares			Class B ordinary shares
Allocation of undistributable income (losses)	$	(359,859	)	$	(9,896	)	$	(126,981	)

Net income (loss) per ordinary share	$	(359,859	)	$	(9,896	)	$	(126,981	)

Weighted average shares outstanding, basic and diluted		27,206,478			748,178			9,600,202

Basic and diluted net income (loss) per ordinary share	$	(0.01	)	$	(0.01	)	$	(0.01	)

Income taxes

The Company accounts for income taxes using the asset and liability approach. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

For tax benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits for the three months ended September 30, 2022 and September 30, 2021 and for the nine months ended September 30, 2022 and for the period from January 27, 2021 (inception) through September 30, 2021. No amounts were accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. As of September 30, 2022, the Company does not have, and does not expect to have, unrecognized tax benefits over the next twelve months.

Recent accounting standards

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity”. This guidance changes how entities account for convertible instruments and contracts in an entity’s own equity and simplifies the accounting for convertible instruments by removing certain separation models for convertible instruments. This guidance also modifies the guidance on diluted earnings per share calculations. This new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company is currently evaluating the impact of this ASU on the financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

NOTE 3. INITIAL PUBLIC OFFERING (“IPO”)

On April 16, 2021, the Company consummated its IPO of 40,000,000 Public Shares, including the 5,000,000 Public Shares as a result of the underwriters’ full exercise of their overallotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $400.0 million, and incurring offering costs of approximately $23.1 million, of which $14.0 million was for deferred underwriting commissions.

F-12

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering on April 16, 2021, the Company consummated the Private Placement of 1,100,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of $11.0 million.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On January 29, 2021, the Company issued 10,000,000 Class B ordinary shares to the Sponsor (the “Founder Shares”) in exchange for the payment of $25,000 from the Sponsor to cover for certain expenses on behalf of the Company. The holders of the Founder Shares agreed to surrender and cancel up to an aggregate of 1,250,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional shares was not exercised in full by the underwriters, so that the Founder Shares would represent approximately 20% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriters fully exercised the over-allotment option on April 16, 2021; thus, these 1,250,000 Founder Shares are no longer subject to forfeiture.

The Founder Shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described in our amended and restated memorandum and articles of association. Such Class A ordinary shares delivered upon conversion will not have any redemption rights or be entitled to liquidating distributions from the Trust Account if we do not consummate an initial business combination.

The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 120 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Related Party Loans

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, on October 26, 2022, the Sponsor made a noncancelable and irrevocable commitment to provide a loan to the Company of up to $1 million to be drawn over the course of 13 months from the date of the letter (“Sponsor Commitment”). Additionally, if the Company completes a Business Combination, the Sponsor or an affiliate of the sponsor or certain of our officers and directors, may, but are not obligated to loan us funds (“Working Capital Loans”) as may be required. If the Company completes a Business Combination, the Company will repay any Working Capital Loans or loan drawn under the Sponsor Commitment (collectively, the “Loans”) out of the proceeds of the Trust Account released to the Company. Otherwise, any Loans will be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay any Loans, but no proceeds held in the Trust Account may be used to repay the Loans. In the event the Company does not have funds sufficient to repay the loan in full upon a liquidation, the Sponsor will waive the balance that exceeds cash available for repayment. The Loans will either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2.0 million of such loan may be convertible into shares of the post Business Combination entity at a price of $10.00 per share. The shares will be identical to the Private Placement Shares. Except for the foregoing, the terms of such Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2022 and December 31, 2021, the Company had no borrowings under the Loans.

Due to Affiliates

Due to affiliates represents expenses paid by affiliates of the Sponsor on behalf of the Company. As of September 30, 2022, the Company had $40 thousand due to affiliates. As of December 31, 2021, the Company had no amounts due to affiliates.

F-13

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration and Shareholder Rights

The holders of the Founder Shares, Private Placement Shares, and shares that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Shares and shares that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights, on or after the date the Company consummates the Business Combination, pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the prospectus to purchase up to 5,000,000 additional shares at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised the over-allotment option on April 16, 2021.

The underwriters were entitled to an underwriting discount of $0.20 per share, or $8.0 million in the aggregate, which was paid upon the closing of the Initial Public Offering. In addition, $0.35 per share, or $14.0 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred underwriting commission will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

NOTE 7. SHAREHOLDERS’ EQUITY (DEFICIT)

Preference Shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share. As of September 30, 2022 and December 31, 2021, there were no preference shares issued or outstanding.

Class A Ordinary Shares — The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of September 30, 2022, and December 31, 2021 there were 41,100,000 Class A ordinary shares issued and outstanding, including 1,100,000 in Private Placement Shares and 40,000,000 in Public Shares subject to possible redemption. The Public Shares are classified as temporary equity, outside of the stockholders’ equity section of the balance sheets. The Private Placement Shares are not subject to redemption and as a result, have been classified as permanent equity on the balance sheets.

Class B Ordinary Shares — The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of $0.0001 per share. On January 29, 2021, the Company issued 10,000,000 Class B ordinary shares to the Sponsor. The holders of such Founder Shares agreed to surrender and cancel up to an aggregate of 1,250,000 Class B ordinary shares for no consideration to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the number of Class B ordinary shares would equal 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. The underwriters fully exercised the over-allotment option on April 16, 2021; thus, these 1,250,000 Class B ordinary shares are no longer subject to forfeiture. As of September 30, 2022 and December 31, 2021, there were 10,000,000 Class B ordinary shares issued and outstanding.

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. Prior to the closing of a Business Combination, the Company may by Ordinary Resolution of the holders of the Class B Shares appoint any person to be a Director or may by Ordinary Resolution of the holders of the Class B Shares remove any Director. For the avoidance of doubt, prior to the closing of a Business Combination, holders of Class A Shares shall have no right to vote on the appointment or removal of any Director.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any private placement shares issued to the Sponsor, its affiliates or any member of our management team, including upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

F-14

Table of Contents

TCV ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(unaudited)

NOTE 8. FAIR VALUE MEASUREMENTS

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

As of September 30, 2022:

Description	Level 1		Level 2		Level 3		Total
Assets:
Marketable securities held in Trust Account	$	402,408,485	$	-	$	-	$	402,408,485

As of December 31, 2021:

Description	Level 1		Level 2		Level 3		Total
Assets:
Marketable securities held in Trust Account	$	400,022,668	$	-	$	-	$	400,022,668

There were no transfers to/from Level 1, 2 and 3 assets as of September 30, 2022 or December 31, 2021.

NOTE 9. STOCK-BASED COMPENSATION

On June 8, 2022, the Sponsor transferred 75,000 shares of Class B common stock to an independent director nominee as compensation for her service on the board of directors. The award will vest simultaneously with the closing of an initial business combination, provided the director has continuously served on the Company’s board of directors through the closing of such initial business combination. As such, the service period for these awards will start on the date of an Initial Business Combination. As the share awards would vest only upon the consummation on a business combination, the compensation expense in relation to these grants would not be recognized until the closing of the initial business combination is considered probable. As of September 30, 2022, no stock-based compensation expense has been recognized.

The fair value of the Class B common stock on the grant date was approximately $4.14 per share. The valuation performed by the Company determined the fair value of the Class B common stock on the date of grant based on the fair value of the Class A shares discounted for a) the probability of a successful business combination, and b) the lack of marketability. The aggregate grant date fair value of the award amounted to approximately $0.3 million.

A summary of the restricted stock award and restricted unit activity for nine months ended September 30, 2022 is as follows:

	Number of Shares
Unvested Shares Outstanding at January 1, 2022		-
Granted		75,000
Forfeited		-
Vested		-
Unvested Outstanding at September 30, 2022		75,000

There were no restricted stock awards or restricted unit activity during the three months ended September 30, 2021 and for the period from January 27, 2021 (inception) through September 30, 2021.

F-15

Table of Contents

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to TCV Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to TCV Acquisition Holdings, L.P., as the holder of the founder shares, and TCV Acquisition Holdings 2, L.P., as the holder of the Private Placement shares, as applicable. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its initial public offering (the “Initial Public Offering”) filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 15, 2021 and the Company’s Annual Report on Form 10-K for the period ended December 31, 2021, as filed with the SEC on March 28, 2022. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated on January 27, 2021 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). We intend to effectuate our initial business combination using cash from the proceeds of our Initial Public Offering and the sale of the private placement shares, our shares, debt or a combination of cash, equity and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activity relates to the Company’s formation, its initial public offering (the “Initial Public Offering”) and looking for a business combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We expect that we will incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for and completing a Business Combination.

Table of Contents

For the three and nine months ended September 30, 2022, we had net income of $1.5 million and $1.4 million, respectively, which consisted primarily of dividend and interest income offset by insurance expense and professional fees . For the three months ended September 30, 2021 and the period from January 27, 2021 (inception) through September 30, 2021, we had net losses of $0.3 million and $0.5 million, respectively, which consisted primarily of insurance expense and professional fees offset by dividend and interest income.

Liquidity and Capital Resources

As of September 30, 2022, a total of $402.4 million was in the Trust Account, and we had $0.2 million of cash equivalents held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. We incurred approximately $23.1 million in transaction costs, including $8.0 million of underwriting fees, $14.0 million of deferred underwriting fees and approximately $1.1 million of other offering costs.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable (if applicable) and deferred underwriting commissions) to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the post-Business Combination entity, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily for paying existing accounts payable, ongoing professional fees, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, on October 26, 2022, our Sponsor made a noncancelable and irrevocable commitment to provide a loan to the Company of up to $1 million to be drawn over the course of 13 months from the date of the letter (“Sponsor Commitment”). In addition, if we complete a Business Combination, our Sponsor or an affiliate of our sponsor or certain of our officers and directors, may, but are not obligated, to loan us funds as may be required. We may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. In the event the Company does not have funds sufficient to repay the loan in full upon a liquidation, the Sponsor will waive the balance that exceeds cash available for repayment. Up to $2.0 million of such loans may be convertible into shares of the post-Business Combination entity at a price of $10.00 per share at the option of the lender.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating and consummating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. The Company has until April 16, 2023, to consummate an initial business combination. It is uncertain that the Company will be able to consummate an initial business combination by this time. If an initial business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

Management continues to evaluate the impact of the COVID-19 pandemic on the industry, along with the rising conflict between Russia and Ukraine, and resulting market volatility. The Company’s business could be also impacted by downturns in the financial markets or in economic conditions, inflation, increases in interest rates. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s business. The condensed financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Table of Contents

The underwriters are entitled to a deferred fee of $0.35 per share, or $14.0 million in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Pursuant to a registration and shareholder rights agreement, the holders of the Class B ordinary shares, Private Placement shares and any shares that may be issued upon conversion of Working Capital Loans will be entitled to registration rights. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering our securities. We will bear the expenses incurred in connection with the filing of any such registration statements.

Critical Accounting Estimates

The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. There were no critical accounting policies that contained significant judgment or estimates. Refer to Note 2 for the Company’s accounting policies.

Recent Accounting Standards

In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This guidance changes how entities account for convertible instruments and contracts in an entity’s own equity and simplifies the accounting for convertible instruments by removing certain separation models for convertible instruments. This guidance also modifies the guidance on diluted earnings per share calculations. This new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company is currently evaluating the impact of this ASU on the financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

ITEM 4.

CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officers and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Table of Contents

Evaluation of Disclosure Controls and Procedures

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officers and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon their evaluation, our Chief Executive Officers and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS.

None.

ITEM 1A.

RISK FACTORS.

Factors that could cause our actual results to differ materially from those in this Quarterly Report include any of the risks described in our final prospectus from our Initial Public Offering filed with the SEC on April 13, 2021 and the Company’s Annual Report on Form 10-K for the period ended December 31, 2021, as filed with the SEC on March 28, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, except as described below, there have been no material changes to the risk factors disclosed in our 2021 Annual Report on Form 10-K. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

The risk factor disclosure in our 2021 Annual Report on Form 10-K filed with the SEC on March 28, 2022, set forth under the heading “Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.” is replaced in its entirety with the following risk factor:

Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results of operations.

On March 30, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving SPACs and private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; effectively eliminating the safe harbor relating to the use of projections in SEC filings in connection with proposed business combination transactions; increasing the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into U.S. federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased, and thus could cause a reduction in the value of our ordinary shares. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a business combination, the exercise of a redemption right, the liquidation of our company or otherwise, may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with a business combination, the exercise of a redemption right, the liquidation of our company or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by us and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in our ability to complete a business combination. Further, the application of the excise tax in the event of a liquidation is uncertain.

Moreover, because these laws, regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may be subject to penalty and our business may be harmed.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On April 16, 2021, we consummated our Initial Public Offering of 40,000,000 shares, which included the full exercise by the underwriters of the over-allotment option to purchase an additional 5,000,000 shares, at $10.00 per share, generating gross proceeds of $400 million. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC acted as book-running managers. The securities sold in the offering were registered under the Securities Act on registration statements on Form S-1 (No. 333- 254505). The SEC declared the registration statement effective on April 13, 2021.

Simultaneously with the consummation of the Initial Public Offering we consummated a private placement of 1,100,000 private placement shares to our sponsor at a price of $10.00 per share, generating total proceeds of $11.0 million. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The private placement shares, which were purchased by TCV Acquisition Holdings 2, L.P., are substantially similar to the Shares, except that if held by TCV Acquisition Holdings 2, L.P. or its permitted transferees they will be subject to transfer restrictions until 30 days following the consummation of the Company’s initial business combination, subject to certain limited exceptions.

Table of Contents

Of the gross proceeds received from the Initial Public Offering including the full exercise of the option to purchase additional shares and the private placement shares, $400.0 million was placed in the Trust Account.

We paid a total of $8.0 million in underwriting commissions and approximately $1.1 million for other offering costs related to the Initial Public Offering. In addition, the underwriters agreed to defer $14.0 million in underwriting commissions.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.

MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5.

OTHER INFORMATION.

None.

ITEM 6.

EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.	Description of Exhibit

3.1	Amended and Restated Memorandum and Articles of Association (1)

4.1	Form of Specimen Class A Ordinary Share Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Form S-1, filed on March 19, 2021 (File No. 333-254505))

10.1	Private Placement Shares Purchase Agreement between the Company and TCV Acquisition Holdings 2, L.P (1)

10.2	Investment Management Trust Account Agreement between Continental Stock Transfer & Trust Company and the Company (1)

10.3	Registration and Shareholder Rights Agreement between the Company and certain security holders (1)

10.4	Letter Agreement between the Company, TCV Acquisition Holdings, L.P., TCV Acquisition Holdings 2, L.P. and each of the officers and directors of the Company (1)

10.5	Form of Indemnity Agreements, dated April 13, 2021, between the Company and each of the officers and directors of the Company (1)

10.6	Promissory Note, dated as of January 29 2021, between the Registrant and the Sponsor (incorporated by reference to Exhibit 10.5 to the Company’s Form S-1, filed on March 19, 2021 (File No. 333-254505))

10.7	Promissory Note Assignment Agreement, dated February 23, 2021, between the Former Sponsor and the Sponsor. (incorporated by reference to Exhibit 10.6 to the Company’s Form S-1, filed on March 19, 2021 (File No. 333-254505))

Table of Contents

31.1*	Certification of Co-Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2*	Certification of Co-Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.3*	Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1*	Certification of Co-Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*	Certification of Co-Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.3*	Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS*	XBRL Instance Document

101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document

101.SCH*	XBRL Taxonomy Extension Schema Document

101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*	XBRL Taxonomy Extension Labels Linkbase Document

101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.

(1)	Previously filed as an exhibit to our Current Report on Form 8-K filed on April 19, 2021 (File No. 001-40327) and incorporated by reference herein.

Table of Contents

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TCV ACQUISITION CORP.

Date: November 14, 2022		/s/ Jon Reynolds, Jr.
	Name:	Jon Reynolds, Jr.
	Title:	Co-Chief Executive Office
		(Principal Executive Officer)

Date: November 14, 2022		/s/ Christopher Marshall
	Name:	Christopher Marshall
	Title:	Co-Chief Executive Office
		(Principal Executive Officer)

Date: November 14, 2022		/s/ Erez Elisha
	Name:	Erez Elisha
	Title:	Chief Financial Officer
		(Principal Financial and Principal Accounting Officer)

TCV Acquisition Corp. 10-Q